Low concentrations of ketamine initiate dendritic atrophy of differentiated GABAergic neurons in culture

Toxicology

Volumn 234, Issue 3, 2007, Pages 216-226

  Vutskits, Laszlo ^a   Gascon, Eduardo ^b   Potter, Gael ^b   Tassonyi, Edomer ^a   Kiss, Jozsef Z ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Dendrite; GABA; Ketamine; Neurotoxicity; Pain

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; KETAMINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ATROPHY; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXPOSURE; DRUG SENSITIVITY; IN VITRO STUDY; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; ATROPHY; CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; DENDRITES; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KETAMINE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34247341033     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.03.004     Document Type: Article

References (40)

1. Adams H.A. Mechanisms of action of ketamine. Anaesthesiol. Reanim. 23 (1998) 60-63
2. Adler C.M., Goldberg T.E., Malhotra A.K., Pickar D., and Breier A. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol. Psychiatry 43 (1998) 811-816
3. Anand K.J., and Soriano S.G. Anesthetic agents and the immature brain: are these toxic or therapeutic?. Anesthesiology 101 (2004) 527-530
4. Arendt-Nielsen L., Nielsen J., Petersen-Felix S., Schnider T.W., and Zbinden A.M. Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain. Br. J. Anaesth. 77 (1996) 625-631
5. Bell R.F., Dahl J.B., Moore R.A., and Kalso E. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev (2006) CD004603
6. Berde C., and Cairns B. Developmental pharmacology across species: promise and problems. Anesth. Analg. 91 (2000) 1-5
7. Edwards S.R., Minto C.F., and Mather L.E. Concurrent ketamine and alfentanil administration: pharmacokinetic considerations. Br. J. Anaesth. 88 (2002) 94-100
8. Feldmeyer D., and Cull-Candy S. Functional consequences of changes in NMDA receptor subunit expression during development. J. Neurocytol. 25 (1996) 857-867
9. Freuchen I., Ostergaard J., Kuhl J.B., and Mikkelsen B.O. Reduction of psychotomimetic side effects of Ketalar (ketamine) by Rohypnol (flunitrazepam). A randomized, double-blind trial. Acta Anaesthesiol. Scand. 20 (1976) 97-103
10. Gascon E., Vutskits L., Zhang H., Barral-Moran M.J., Kiss P.J., Mas C., and Kiss J.Z. Sequential activation of p75 and TrkB is involved in dendritic development of subventricular zone-derived neuronal progenitors in vitro. Eur. J. Neurosci. 21 (2005) 69-80
11. Gascon E., Dayer A.G., Sauvain M.O., Potter G., Jenny B., De Roo M., Zgraggen E., Demaurex N., Muller D., and Kiss J.Z. GABA regulates dendritic growth by stabilizing lamellipodia in newly generated interneurons of the olfactory bulb. J. Neurosci. 26 (2006) 12956-12966
12. Himmelseher S., and Durieux M.E. Ketamine for perioperative pain management. Anesthesiology 102 (2005) 211-220
13. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., and Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283 (1999) 70-74
14. Jevtovic-Todorovic V., Wozniak D.F., Benshoff N.D., and Olney J.W. A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide. Brain Res. 895 (2001) 264-267
15. Kew J.N., Richards J.G., Mutel V., and Kemp J.A. Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons. J. Neurosci. 18 (1998) 1935-1943
16. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers Jr. M.B., and Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51 (1994) 199-214
17. Lossignol D.A., Obiols-Portis M., and Body J.J. Successful use of ketamine for intractable cancer pain. Support. Care Cancer 13 (2005) 188-193
18. Malinovsky J.M., Servin F., Cozian A., Lepage J.Y., and Pinaud M. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. Br. J. Anaesth. 77 (1996) 203-207
19. Olney J.W. New insights and new issues in developmental neurotoxicology. Neurotoxicology 23 (2002) 659-668
20. Olney J.W., Labruyere J., and Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244 (1989) 1360-1362
21. Olney J.W., Young C., Wozniak D.F., Ikonomidou C., and Jevtovic-Todorovic V. Anesthesia-induced developmental neuroapoptosis. Does it happen in humans?. Anesthesiology 101 (2004) 273-275
22. Orser B.A., Pennefather P.S., and MacDonald J.F. Multiple mechanisms of ketamine blockade of N-methyl-d-aspartate receptors. Anesthesiology 86 (1997) 903-917
23. Oye I., Paulsen O., and Maurset A. Effects of ketamine on sensory perception: evidence for a role of N-methyl-d-aspartate receptors. J. Pharmacol. Exp. Ther. 260 (1992) 1209-1213
24. Petrenko A.B., Yamakura T., Baba H., and Shimoji K. The role of N-methyl-d-aspartate (NMDA) receptors in pain: a review. Anesth. Analg. 97 (2003) 1108-1116
25. Reich D.L., and Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can. J. Anaesth. 36 (1989) 186-197
26. Robinson T.E., and Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 Suppl 1 (2004) 33-46
27. Rowbotham M.C. Pharmacologic management of complex regional pain syndrome. Clin. J. Pain. 22 (2006) 425-429
28. Rowland L.M., Astur R.S., Jung R.E., Bustillo J.R., Lauriello J., and Yeo R.A. Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 30 (2005) 633-639
29. Scallet A.C., Schmued L.C., Slikker Jr. W., Grunberg N., Faustino P.J., Davis H., Lester D., Pine P.S., Sistare F., and Hanig J.P. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol. Sci. 81 (2004) 364-370
30. Spielmann H., and Liebsch M. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice. Toxicol. In Vitro 15 (2001) 585-590
31. Suzuki M., Kinoshita T., Kikutani T., Yokoyama K., Inagi T., Sugimoto K., Haraguchi S., Hisayoshi T., and Shimada Y. Determining the plasma concentration of ketamine that enhances epidural bupivacaine-and-morphine-induced analgesia. Anesth. Analg. 101 (2005) 777-784
32. van Ooyen A., Duijnhouwer J., Remme M.W., and van Pelt J. The effect of dendritic topology on firing patterns in model neurons. Network 13 (2002) 311-325
33. Vick P.G., and Lamer T.J. Treatment of central post-stroke pain with oral ketamine. Pain 92 (2001) 311-313
34. Vranken J.H., Troost D., Wegener J.T., Kruis M.R., and van der Vegt M.H. Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain. Pain 117 (2005) 231-235
35. Vutskits L., Gascon E., Tassonyi E., and Kiss J.Z. Clinically relevant concentrations of propofol but not midazolam alter in vitro dendritic development of isolated gamma-aminobutyric acid-positive interneurons. Anesthesiology 102 (2005) 970-976
36. Vutskits L., Gascon E., Tassonyi E., and Kiss J.Z. Effect of ketamine on dendritic arbor development and survival of immature GABAergic neurons in vitro. Toxicol. Sci. 91 (2006) 540-549
37. Weber F., Wulf H., Gruber M., and Biallas R. S-ketamine and s-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children. Paediatr. Anaesth. 14 (2004) 983-988
38. Williams D.W., and Truman J.W. Cellular mechanisms of dendrite pruning in Drosophila: insights from in vivo time-lapse of remodeling dendritic arborizing sensory neurons. Development 132 (2005) 3631-3642
39. Williams K., Russell S.L., Shen Y.M., and Molinoff P.B. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron. 10 (1993) 267-278
40. Young C., Jevtovic-Todorovic V., Qin Y.Q., Tenkova T., Wang H., Labruyere J., and Olney J.W. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J. Pharmacol. 146 (2005) 189-197